Pages that link to "Item:Q3526173"
From MaRDI portal
The following pages link to Monitoring late-onset toxicities in phase I trials using predicted risks (Q3526173):
Displaying 9 items.
- Adaptive isotonic estimation of the minimum effective and peak doses in the presence of covariates (Q419309) (← links)
- Bayesian models and decision algorithms for complex early phase clinical trials (Q903294) (← links)
- Adaptive clinical trial designs for phase I cancer studies (Q2452091) (← links)
- Using joint utilities of the times to response and toxicity to adaptively optimize schedule-dose regimes (Q2861956) (← links)
- Time-to-event continual reassessment method incorporating treatment cycle information with application to an oncology phase I trial (Q2931051) (← links)
- Risk-Group-Specific Dose Finding Based on an Average Toxicity Score (Q3576932) (← links)
- Epidemiologic Assessment of Risks of Adverse Reactions Associated with Intermittent Exposure (Q4274322) (← links)
- Review of Statistical Treatment for Oncology Dose-Escalation Trial with Prolonged Evaluation Window or Fast Enrollment (Q5051094) (← links)
- The adaptive accelerated biased coin design for phase I clinical trials (Q5124969) (← links)
